{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "32696819", "DateCompleted": {"Year": "2020", "Month": "07", "Day": "31"}, "DateRevised": {"Year": "2020", "Month": "07", "Day": "31"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2020", "Month": "07", "Day": "17"}], "ELocationID": ["S0100-879X2020000900604", "10.1590/1414-431x20209717"], "Journal": {"ISSN": "1414-431X", "JournalIssue": {"Volume": "53", "Issue": "9", "PubDate": {"Year": "2020"}}, "Title": "Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas", "ISOAbbreviation": "Braz J Med Biol Res"}, "ArticleTitle": "Identification of potential molecular mechanisms and small molecule drugs in myocardial ischemia/reperfusion injury.", "Pagination": {"StartPage": "0", "MedlinePgn": "0"}, "Abstract": {"AbstractText": ["Myocardial ischemia/reperfusion (MI/R) injury is a complex phenomenon that causes severe damage to the myocardium. However, the potential molecular mechanisms of MI/R injury have not been fully clarified. We identified potential molecular mechanisms and therapeutic targets in MI/R injury through analysis of Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) were found between MI/R injury and normal samples, and overlapping DEGs were found between GSE61592 and GSE67308. Gene Ontology (GO) and pathway analysis were performed for overlapping DEGs by Database for Annotation, Visualization and Integration Discovery (DAVID). Then, a network of protein-protein interaction (PPI) was constructed through the Search Tool for the Retrieval of Interacting Genes (STRING) database. Potential microRNAs (miRNAs) and therapeutic small molecules were screened out using microRNA.org database and the Comparative Toxicogenomics database (CTD), respectively. Finally, we identified 21 overlapping DEGs related to MI/R injury. These DEGs were significantly enriched in IL-17 signaling pathway, cytosolic DNA-sensing pathway, chemokine signaling, and cytokine-cytokine receptor interaction pathway. According to the degree in the PPI network, CCL2, LCN2, HP, CCL7, HMOX1, CCL4, and S100A8 were found to be hub genes. Furthermore, we identified potential miRNAs (miR-24-3p, miR-26b-5p, miR-2861, miR-217, miR-4251, and miR-124-3p) and therapeutic small molecules like ozone, troglitazone, rosiglitazone, and n-3 polyunsaturated fatty acids for MI/R injury. These results identified hub genes and potential small molecule drugs, which could contribute to the understanding of molecular mechanisms and treatment for MI/R injury."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Third Clinical Medical College, Chongqing Medical University, Chongqing, China."}], "LastName": "Jiang", "ForeName": "Tao", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Third Clinical Medical College, Chongqing Medical University, Chongqing, China."}], "LastName": "Liu", "ForeName": "Yingcun", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Third Clinical Medical College, Chongqing Medical University, Chongqing, China."}], "LastName": "Chen", "ForeName": "Biao", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Third Clinical Medical College, Chongqing Medical University, Chongqing, China."}], "LastName": "Si", "ForeName": "Liangyi", "Initials": "L"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Brazil", "MedlineTA": "Braz J Med Biol Res", "NlmUniqueID": "8112917", "ISSNLinking": "0100-879X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "MIRN217 microRNA, human"}, {"RegistryNumber": "0", "NameOfSubstance": "MicroRNAs"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Computational Biology"}, {"QualifierName": [], "DescriptorName": "Gene Expression Profiling"}, {"QualifierName": [], "DescriptorName": "Gene Ontology"}, {"QualifierName": [], "DescriptorName": "Gene Regulatory Networks"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "MicroRNAs"}, {"QualifierName": [], "DescriptorName": "Myocardial Reperfusion Injury"}, {"QualifierName": [], "DescriptorName": "Protein Interaction Maps"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Tejada T, Tan L, Torres RA, Calvert JW, Lambert JP, Zaidi M, et al. IGF-1 degradation by mouse mast cell protease 4 promotes cell death and adverse cardiac remodeling days after a myocardial infarction. Proc Natl Acad Sci USA. 2016;113:6949\u20136954. doi: 10.1073/pnas.1603127113.", "ArticleIdList": ["10.1073/pnas.1603127113", "PMC4922143", "27274047"]}, {"Citation": "Koeppen M, Lee JW, Seo SW, Brodsky KS, Kreth S, Yang IV, et al. Hypoxia-inducible factor 2-alpha-dependent induction of amphiregulin dampens myocardial ischemia-reperfusion injury. Nat Commun. 2018;9:816. doi: 10.1038/s41467-018-03105-2.", "ArticleIdList": ["10.1038/s41467-018-03105-2", "PMC5827027", "29483579"]}, {"Citation": "Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27\u201330. doi: 10.1093/nar/28.1.27.", "ArticleIdList": ["10.1093/nar/28.1.27", "PMC102409", "10592173"]}, {"Citation": "Dennis G, Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, et al. DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol. 2003;4:P3. doi: 10.1186/gb-2003-4-5-p3.", "ArticleIdList": ["10.1186/gb-2003-4-5-p3", "12734009"]}, {"Citation": "Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 2013;41:D808\u2013D815. doi: 10.1093/nar/gks1094.", "ArticleIdList": ["10.1093/nar/gks1094", "PMC3531103", "23203871"]}, {"Citation": "Betel D, Wilson M, Gabow A, Marks DS, Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res. 2008;36:D149\u2013D153. doi: 10.1093/nar/gkm995.", "ArticleIdList": ["10.1093/nar/gkm995", "PMC2238905", "18158296"]}, {"Citation": "Davis AP, Grondin CJ, Johnson RJ, Sciaky D, McMorran R, Wiegers J, et al. The comparative toxicogenomics database: update 2019. Nucleic Acids Res. 2019;47:D948\u2013D954. doi: 10.1093/nar/gky868.", "ArticleIdList": ["10.1093/nar/gky868", "PMC6323936", "30247620"]}, {"Citation": "Liao YH, Xia N, Zhou SF, Tang TT, Yan XX, Lv BJ, et al. Interleukin-17A contributes to myocardial ischemia/reperfusion injury by regulating cardiomyocyte apoptosis and neutrophil infiltration. J Am Coll Cardiol. 2012;59:420\u2013429. doi: 10.1016/j.jacc.2011.10.863.", "ArticleIdList": ["10.1016/j.jacc.2011.10.863", "PMC3262985", "22261166"]}, {"Citation": "Kumar AG, Ballantyne CM, Michael LH, Kukielka GL, Youker KA, ML Lindsey, et al. Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium. Circulation. 1997;95:693\u2013700. doi: 10.1161/01.CIR.95.3.693.", "ArticleIdList": ["10.1161/01.CIR.95.3.693", "9024159"]}, {"Citation": "Birdsall HH, Green DM, Trial J, Youker KA, Burns AR, MacKay CR, et al. Complement C5a, TGF-beta 1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion. Circulation. 1997;95:684\u2013692. doi: 10.1161/01.CIR.95.3.684.", "ArticleIdList": ["10.1161/01.CIR.95.3.684", "9024158"]}, {"Citation": "Morimoto H, Hirose M, Takahashi M, Kawaguchi M, Ise H, Kolattukudy PE, et al. MCP-1 induces cardioprotection against ischaemia/reperfusion injury: role of reactive oxygen species. Cardiovasc Res. 2008;78:554\u2013562. doi: 10.1093/cvr/cvn035.", "ArticleIdList": ["10.1093/cvr/cvn035", "18267955"]}, {"Citation": "Cheng L, Xing H, Mao X, Li L, Li X, Li Q. Lipocalin-2 promotes m1 macrophages polarization in a mouse cardiac ischaemia-reperfusion injury model. Scand J Immunol. 2015;81:31\u201338. doi: 10.1111/sji.12245.", "ArticleIdList": ["10.1111/sji.12245", "25359467"]}, {"Citation": "Li Y, Chen B, Yang X, Zhang C, Jiao Y, Li P, et al. S100a8/a9 signaling causes mitochondrial dysfunction and cardiomyocyte death in response to ischemic/reperfusion injury. Circulation. 2019;140:751\u2013764. doi: 10.1161/CIRCULATIONAHA.118.039262.", "ArticleIdList": ["10.1161/CIRCULATIONAHA.118.039262", "31220942"]}, {"Citation": "Volz HC, Laohachewin D, Seidel C, Lasitschka F, Keilbach K, Wienbrandt AR, et al. S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-kappaB signaling. Basic Res Cardiol. 2012;107:250. doi: 10.1007/s00395-012-0250-z.", "ArticleIdList": ["10.1007/s00395-012-0250-z", "22318783"]}, {"Citation": "Arslan F, Smeets MB, Buttari B, Profumo E, Rigano R, Akeroyd L, et al. Lack of haptoglobin results in unbalanced VEGFalpha/angiopoietin-1 expression, intramural hemorrhage and impaired wound healing after myocardial infarction. J Mol Cell Cardiol. 2013;56:116\u2013128. doi: 10.1016/j.yjmcc.2012.12.012.", "ArticleIdList": ["10.1016/j.yjmcc.2012.12.012", "23274064"]}, {"Citation": "Chiang KH, Kao YT, Leu HB, Huang PH, Huang SS, Cheng TM, et al. Higher post-acute myocardial infarction plasma haptoglobin level is associated with poor long-term overall survival. Int J Cardiol. 2017;229:102\u2013107. doi: 10.1016/j.ijcard.2016.11.220.", "ArticleIdList": ["10.1016/j.ijcard.2016.11.220", "27913007"]}, {"Citation": "Wu ML, Ho YC, Yet SF. A central role of heme oxygenase-1 in cardiovascular protection. Antioxid Redox Signal. 2011;15:1835\u20131846. doi: 10.1089/ars.2010.3726.", "ArticleIdList": ["10.1089/ars.2010.3726", "21091076"]}, {"Citation": "Chen SM, Li YG, Wang DM. Study on changes of heme oxygenase-1 expression in patients with coronary heart disease. Clin Cardiol. 2005;28:197\u2013201. doi: 10.1002/clc.4960280410.", "ArticleIdList": ["10.1002/clc.4960280410", "PMC6654511", "15869055"]}, {"Citation": "Hinkel R, Lange P, Petersen B, Gottlieb E, Ng JK, Finger S, et al. Heme oxygenase-1 gene therapy provides cardioprotection via control of post-ischemic inflammation: an experimental study in a pre-clinical pig model. J Am Coll Cardiol. 2015;66:154\u2013165. doi: 10.1016/j.jacc.2015.04.064.", "ArticleIdList": ["10.1016/j.jacc.2015.04.064", "26160631"]}, {"Citation": "Chen D, Jin Z, Zhang J, Jiang L, Chen K, He X, et al. HO-1 Protects against hypoxia/reoxygenation-induced mitochondrial dysfunction in H9c2 cardiomyocytes. PLoS One. 2016;11:e0153587. doi: 10.1371/journal.pone.0153587.", "ArticleIdList": ["10.1371/journal.pone.0153587", "PMC4854406", "27138700"]}, {"Citation": "Xiao X, Lu Z, V Lin, May A, Shaw DH, Wang Z, et al. MicroRNA miR-24-3p reduces apoptosis and regulates keap1-Nrf2 pathway in mouse cardiomyocytes responding to ischemia/reperfusion injury. Oxid Med Cell Longev. 2018;2018:7042105. doi: 10.1155/2018/7042105.", "ArticleIdList": ["10.1155/2018/7042105", "PMC6304907", "30622671"]}, {"Citation": "Jakob P, Kacprowski T, Briand-Schumacher S, Heg D, Klingenberg R, Stahli BE, et al. Profiling and validation of circulating microRNAs for cardiovascular events in patients presenting with ST-segment elevation myocardial infarction. Eur Heart J. 2017;38:511\u2013515. doi: 10.1093/eurheartj/ehw563.", "ArticleIdList": ["10.1093/eurheartj/ehw563", "28011706"]}, {"Citation": "Ruan Z, Wang S, Yu W, Deng F. LncRNA MALAT1 aggravates inflammation response through regulating PTGS2 by targeting miR-26b in myocardial ischemia-reperfusion injury. Int J Cardiol. 2019;288:122. doi: 10.1016/j.ijcard.2019.04.015.", "ArticleIdList": ["10.1016/j.ijcard.2019.04.015", "31101226"]}, {"Citation": "Wang K, Long B, Li N, Li L, Liu CY, Dong YH, et al. MicroRNA-2861 regulates programmed necrosis in cardiomyocyte by impairing adenine nucleotide translocase 1 expression. Free Radic Biol Med. 2016;91:58\u201367. doi: 10.1016/j.freeradbiomed.2015.11.031.", "ArticleIdList": ["10.1016/j.freeradbiomed.2015.11.031", "26654759"]}, {"Citation": "Yao Y, Fan X, Yu B, Li T, Zhang Y. Knockdown of long noncoding RNA Malat1 aggravates hypoxia-induced cardiomyocyte injury by targeting miR-217. Adv Clin Exp Med. 2019;28:719\u2013728. doi: 10.17219/acem/93878.", "ArticleIdList": ["10.17219/acem/93878", "30843674"]}, {"Citation": "Liu BF, Chen Q, Zhang M, Zhu YK. MiR-124 promotes ischemia-reperfusion induced cardiomyocyte apoptosis by targeting sphingosine kinase 1. Eur Rev Med Pharmacol Sci. 2019;23:7049\u20137058.", "ArticleIdList": ["31486506"]}, {"Citation": "Meng W, Xu Y, Li D, Zhu E, Deng L, Liu Z, et al. Ozone protects rat heart against ischemia-reperfusion injury: a role for oxidative preconditioning in attenuating mitochondrial injury. Biomed Pharmacother. 2017;88:1090\u20131097. doi: 10.1016/j.biopha.2017.01.151.", "ArticleIdList": ["10.1016/j.biopha.2017.01.151", "28192883"]}, {"Citation": "Di Filippo C, Luongo M, Marfella R, Ferraraccio F, Lettieri B, Capuano A, et al. Oxygen/ozone protects the heart from acute myocardial infarction through local increase of eNOS activity and endothelial progenitor cells recruitment. Naunyn Schmiedebergs Arch Pharmacol. 2010;382:287\u2013291. doi: 10.1007/s00210-010-0545-2.", "ArticleIdList": ["10.1007/s00210-010-0545-2", "20694792"]}, {"Citation": "Di Filippo C, Cervone C, Rossi C, di Ronza C, Marfella R, Capodanno P, et al. Antiarrhythmic effect of acute oxygen-ozone administration to rats. Eur J Pharmacol. 2010;629:89\u201395. doi: 10.1016/j.ejphar.2009.11.061.", "ArticleIdList": ["10.1016/j.ejphar.2009.11.061", "19958767"]}, {"Citation": "Zhu P, Lu L, Xu Y, Schwartz GG. Troglitazone improves recovery of left ventricular function after regional ischemia in pigs. Circulation. 2000;101:1165\u20131171. doi: 10.1161/01.CIR.101.10.1165.", "ArticleIdList": ["10.1161/01.CIR.101.10.1165", "PMC3633448", "10715264"]}, {"Citation": "Xu Y, Lu L, Greyson C, Lee J, Gen M, Kinugawa K, et al. Deleterious effects of acute treatment with a peroxisome proliferator-activated receptor-gamma activator in myocardial ischemia and reperfusion in pigs. Diabetes. 2003;52:1187\u20131194. doi: 10.2337/diabetes.52.5.1187.", "ArticleIdList": ["10.2337/diabetes.52.5.1187", "PMC3633427", "12716751"]}, {"Citation": "Yue Tl TL, Chen J, Bao W, Narayanan PK, Bril A, Jiang W, et al. In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Circulation. 2001;104:2588\u20132594. doi: 10.1161/hc4601.099403.", "ArticleIdList": ["10.1161/hc4601.099403", "11714655"]}, {"Citation": "Home PD, Pocock SJ, Beck-Nielsen H, Curtis PS, Gomis R, Hanefeld M, et al. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. Lancet. 2009;373:2125\u20132135. doi: 10.1016/S0140-6736(09)60953-3.", "ArticleIdList": ["10.1016/S0140-6736(09)60953-3", "19501900"]}, {"Citation": "Florez H, Reaven PD, Bahn G, Moritz T, Warren S, Marks J, et al. Rosiglitazone treatment and cardiovascular disease in the veterans affairs diabetes trial. Diabetes Obes Metab. 2015;17:949\u2013955. doi: 10.1111/dom.12487.", "ArticleIdList": ["10.1111/dom.12487", "PMC4676911", "25964070"]}, {"Citation": "Burban M, Meyer G, Olland A, Severac F, Yver B, Toti F, et al. An intravenous bolus of epa: Dha 6: 1 protects against myocardial ischemia-reperfusion-induced shock. Shock. 2016;46:549\u2013556. doi: 10.1097/SHK.0000000000000624.", "ArticleIdList": ["10.1097/SHK.0000000000000624", "27058043"]}, {"Citation": "Pepe S, McLennan PL. Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and postischemic recovery of contractile function. Circulation. 2002;105:2303\u20132308. doi: 10.1161/01.CIR.0000015604.88808.74.", "ArticleIdList": ["10.1161/01.CIR.0000015604.88808.74", "12010914"]}, {"Citation": "Blacher J, Czernichow S, Paillard F, Ducimetiere P, Hercberg S, Galan P. Cardiovascular effects of B-vitamins and/or N-3 fatty acids: the SU.FOL.OM3 trial. Int J Cardiol. 2013;167:508\u2013513. doi: 10.1016/j.ijcard.2012.01.060.", "ArticleIdList": ["10.1016/j.ijcard.2012.01.060", "22365647"]}, {"Citation": "Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet. 1999;354:447\u2013455. doi: 10.1016/S0140-6736(99)07072-5.", "ArticleIdList": ["10.1016/S0140-6736(99)07072-5", "10465168"]}, {"Citation": "Coates AM, Sioutis S, Buckley JD, Howe PR. Regular consumption of n-3 fatty acid-enriched pork modifies cardiovascular risk factors. Br J Nutr. 2009;101:592\u2013597. doi: 10.1017/S0007114508025063.", "ArticleIdList": ["10.1017/S0007114508025063", "18590592"]}, {"Citation": "Hidayat K, Yang J, Zhang Z, Chen GC, Qin LQ, Eggersdorfer M, et al. Effect of omega-3 long-chain polyunsaturated fatty acid supplementation on heart rate: a meta-analysis of randomized controlled trials. Eur J Clin Nutr. 2018;72:805\u2013817. doi: 10.1038/s41430-017-0052-3.", "ArticleIdList": ["10.1038/s41430-017-0052-3", "PMC5988646", "29284786"]}], "ReferenceList": []}], "History": [{"Year": "2019", "Month": "12", "Day": "17"}, {"Year": "2020", "Month": "6", "Day": "2"}, {"Year": "2020", "Month": "7", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "8", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "17"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32696819", "PMC7372942", "10.1590/1414-431x20209717", "S0100-879X2020000900604"]}}], "PubmedBookArticle": []}